Candida albicans HSP90 Recombinant Protein, N-His

Introducing Candida albicans HSP90 Recombinant Protein, N-His – Your Key to Unlocking the Secrets of Fungal Infections

Candida albicans is a common fungal pathogen that can cause a range of infections in humans, from superficial skin and mucosal infections to life-threatening systemic infections. As the incidence of fungal infections continues to rise, there is a growing need for effective treatments. This is where Candida albicans HSP90 Recombinant Protein, N-His comes in.

Biological Function:

Candida albicans HSP90 (Heat Shock Protein 90) is a highly conserved molecular chaperone that plays a crucial role in the proper folding, stability, and function of proteins in the cell. It is essential for the survival and virulence of Candida albicans, making it an attractive target for drug development.

Main Applications:

The recombinant form of Candida albicans HSP90, with an N-terminal His tag, is a valuable tool for researchers studying fungal infections. It can be used in a variety of applications, including:

1. Drug Discovery: Candida albicans HSP90 has been identified as a potential target for antifungal drugs. By using the recombinant protein in drug screening assays, researchers can identify compounds that inhibit its function and potentially lead to new treatments for fungal infections.

2. Protein-Protein Interaction Studies: HSP90 is known to interact with a wide range of proteins involved in various cellular processes. By using the recombinant protein, researchers can study these interactions and gain insights into the mechanisms of Candida albicans virulence.

3. Structural Studies: The recombinant protein can be used for structural studies, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, to determine the 3D structure of HSP90. This information is crucial for understanding its function and designing drugs that specifically target it.

Experimental Use Cases:

Candida albicans HSP90 Recombinant Protein, N-His has been successfully used in various research studies, including:

1. In vitro inhibition studies: The recombinant protein has been used to assess the inhibitory activity of potential drug candidates against Candida albicans HSP90.

2. Co-immunoprecipitation assays: By using the recombinant protein, researchers have identified novel protein-protein interactions involving HSP90 in Candida albicans.

3. Structural studies: The recombinant protein has been used to determine the crystal structure of Candida albicans HSP90, providing valuable insights into its function and potential drug targets.

In summary, Candida albicans HSP90 Recombinant Protein, N-His is a versatile tool for researchers studying fungal infections. Its biological function, main applications, and successful use cases highlight its importance in the fight against Candida albicans and other fungal pathogens. So, why wait? Add it to your research arsenal today and unlock the secrets of fungal infections.